Avadel Pharmaceuticals Expands Leadership Team with Three Strategic Hires
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
DUBLIN, Ireland, Feb. 25, 2021 (GLOBE NEWSWIRE) Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in adults with narcolepsy, announced today that members of the Avadel management team will participate in fireside chats at the H.C. Wainwright Global Life Sciences Conference and Oppenheimer 31st Annual Healthcare Conference which are being held in March 2021. Fireside Chat Details:Event:H.C. Wainwright Global Life Sciences ConferenceDate:March 9thWebcast:A webcast of this event will be available starting at 7 a.m. ET on Tuesday, March 9th, at (click here), as well as on Avadel’s website, www.avadel.com, with an archive available for 90 days. Event:Oppenheimer 31st Annual Healthcare ConferenceTime and Date:3:10 p.m. ET on Wednesday, March 17th Webcast:A live webcast of this event, as well as an archived recording, will be available
Press release content from Business Wire. The AP news staff was not involved in its creation.
Outlook on the Excessive Daytime Sleepiness (EDS) Market to 2030 - Insight, Epidemiology and Market Forecast - 2030 - ResearchAndMarkets.com
February 2, 2021 GMT
DUBLIN (BUSINESS WIRE) Feb 2, 2021
This report delivers an in-depth understanding of the EDS, historical and forecasted epidemiology as well as the EDS market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
ADVERTISEMENT
The EDS market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM EDS market size from 2017 to 2030. The Report also covers current EDS treatment practices, market drivers, market barriers, unmet medical needs, SWOT analysis to curate the best of the opportunities, and assesses the underlying potential of the market.